Amaya Gascó MD/PhD
@amayagasco.bsky.social
Medical Oncologist/ Clinical Development and Global Medical Affairs Executive/ Clinical and Medical Strategist / Precision Medicine
Reposted by Amaya Gascó MD/PhD
Excited to share the launch of our new tissue-informed whole genome sequencing molecular residual disease (Tissue-informed #WGS #MRD)test for research use in early to late-stage cancers through our FlexOMx™ Lab. Read more: spkl.io/63323ArxYJ
September 23, 2025 at 1:02 PM
Excited to share the launch of our new tissue-informed whole genome sequencing molecular residual disease (Tissue-informed #WGS #MRD)test for research use in early to late-stage cancers through our FlexOMx™ Lab. Read more: spkl.io/63323ArxYJ